Artwork
iconShare
 
Manage episode 490294516 series 2676306
Content provided by Information Technology and Innovation Foundation (ITIF) — The Leading Think Tank for Science and Tech Policy, Information Technology, Innovation Foundation (ITIF) — The Leading Think Tank for Science, and Tech Policy. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Information Technology and Innovation Foundation (ITIF) — The Leading Think Tank for Science and Tech Policy, Information Technology, Innovation Foundation (ITIF) — The Leading Think Tank for Science, and Tech Policy or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Continued innovation and investment is vital to maintaining the U.S.'s leadership in the biopharma sector. Rob and Jackie sit down with Andrew Geall, Chief Development Officer at Replicate Bioscience, and Deborah Barbara, strategic advisor to Primrose Bio, to discuss the development and potential of mRNA as the fourth pillar of pharmaceutical innovation.

Mentioned

Related

  continue reading

102 episodes